American Society of Hirudotherapy

Medicinal Leech CNS as a Model for Exosome Studies in the Crosstalk between Microglia and Neurons

Basic science / preclinical published in International journal of molecular sciences (2018)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomics & ProteomicsRaffo-Romero A et al. · International journal of molecular sciences, 2018

Abstract

In healthy or pathological brains, the neuroinflammatory state is supported by a strong communication involving microglia and neurons. Recent studies indicate that extracellular vesicles (EVs), including exosomes and microvesicles, play a key role in the physiological interactions between cells allowing central nervous system (CNS) development and/or integrity. The present report used medicinal leech CNS to investigate microglia/neuron crosstalk from ex vivo approaches as well as primary cultures. The results demonstrated a large production of exosomes from microglia. Their incubation to primary neuronal cultures showed a strong interaction with neurites. In addition, neurite outgrowth assays demonstrated microglia exosomes to exhibit significant neurotrophic activities using at least a Transforming Growth Factor beta (TGF-β) family member, called nGDF (nervous Growth/Differentiation Factor). Of interest, the results also showed an EV-mediated dialog between leech microglia and rat cells highlighting this communication to be more a matter of molecules than of species. Taken together, the present report brings a new insight into the microglia/neuron crosstalk in CNS and would help deciphering the molecular evolution of such a cell communication in brain.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAmino Acid SequenceAnimalsCentral Nervous SystemCoculture TechniquesExosomesHirudo medicinalisMicrogliaNerve Growth FactorsNeuritesNeuronsRNA, Messenger

Summary

In healthy or pathological brains, the neuroinflammatory state is supported by a strong communication involving microglia and neurons. Recent studies indicate that extracellular vesicles (EVs), including exosomes and microvesicles, play a key role in the physiological interactions between cells allowing central nervous system (CNS) development a...

Why This Matters for Hirudotherapy

This study used medicinal leech central nervous system tissue, through ex vivo approaches and primary cultures, to investigate how exosomes produced by microglia communicate with neurons and influence neurite outgrowth. The findings showed that microglia-derived exosomes exhibited significant neurotrophic activity mediated at least partly by a TGF-β family member called nGDF, and that extracellular vesicle-mediated communication occurred between leech microglia and rat cells, suggesting the process is governed more by conserved molecules than by species identity. For ASH's domain, this work is relevant because it uses medicinal leech tissue to characterize bioactive molecules involved in neural repair and neuroprotection, themes conceptually adjacent to therapeutic interest in leech-derived bioactive compounds. However, the study examines CNS microglia-neuron signaling rather than leech salivary secretions or clinical hirudotherapy, and the neurotrophic effects are demonstrated in culture systems rather than therapeutic contexts; its connection to hirudotherapy is indirect and limited to the leech as a research model.

Citation

Medicinal Leech CNS as a Model for Exosome Studies in the Crosstalk between Microglia and Neurons.

Raffo-Romero A et al. · International journal of molecular sciences, 2018

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.